Literature DB >> 28835505

Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Sharmila Nair1, Subhajit Poddar2, Raeann M Shimak2, Michael S Diamond3,2,4,5.   

Abstract

The innate immune system protects cells against viral pathogens in part through the autocrine and paracrine actions of alpha/beta interferon (IFN-α/β) (type I), IFN-γ (type II), and IFN-λ (type III). The transcription factor interferon regulatory factor 1 (IRF-1) has a demonstrated role in shaping innate and adaptive antiviral immunity by inducing the expression of IFN-stimulated genes (ISGs) and mediating signals downstream of IFN-γ. Although ectopic expression experiments have suggested an inhibitory function of IRF-1 against infection of alphaviruses in cell culture, its role in vivo remains unknown. Here, we infected Irf1 -/- mice with two distantly related arthritogenic alphaviruses, chikungunya virus (CHIKV) and Ross River virus (RRV), and assessed the early antiviral functions of IRF-1 prior to induction of adaptive B and T cell responses. IRF-1 expression limited CHIKV-induced foot swelling in joint-associated tissues and prevented dissemination of CHIKV and RRV at early time points. Virological and histological analyses revealed greater infection of muscle tissues in Irf1 -/- mice than in wild-type mice. The antiviral actions of IRF-1 appeared to be independent of the induction of type I IFN or the effects of type II and III IFNs but were associated with altered local proinflammatory cytokine and chemokine responses and differential infiltration of myeloid cell subsets. Collectively, our in vivo experiments suggest that IRF-1 restricts CHIKV and RRV infection in stromal cells, especially muscle cells, and that this controls local inflammation and joint-associated swelling.IMPORTANCE Interferon regulatory factor 1 (IRF-1) is a transcription factor that regulates the expression of a broad range of antiviral host defense genes. In this study, using Irf1 -/- mice, we investigated the role of IRF-1 in modulating pathogenesis of two related arthritogenic alphaviruses, chikungunya virus and Ross River virus. Our studies show that IRF-1 controlled alphavirus replication and swelling in joint-associated tissues within days of infection. Detailed histopathological and virological analyses revealed that IRF-1 preferentially restricted CHIKV infection in cells of nonhematopoietic lineage, including muscle cells. The antiviral actions of IRF-1 resulted in decreased local inflammatory responses in joint-associated tissues, which prevented immunopathology.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Ross River virus; alphavirus; chikungunya virus; interferon; interferon regulatory factor 1; interferon-stimulated genes

Year:  2017        PMID: 28835505      PMCID: PMC5660487          DOI: 10.1128/JVI.01419-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Distinct activation of murine interferon-alpha promoter region by IRF-1/ISFG-2 and virus infection.

Authors:  W C Au; N B Raj; R Pine; P M Pitha
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

2.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

3.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

Review 4.  Innate immune response to viral infection.

Authors:  Shohei Koyama; Ken J Ishii; Cevayir Coban; Shizuo Akira
Journal:  Cytokine       Date:  2008-08-09       Impact factor: 3.861

5.  Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection.

Authors:  R Pine
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  An animal model for studying the pathogenesis of chikungunya virus infection.

Authors:  Sarah A Ziegler; Liang Lu; Amelia P A Travassos da Rosa; Shu-Yuan Xiao; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2008-07       Impact factor: 2.345

7.  Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Authors:  Dirk Schlüter; Lai-Yu Kwok; Sonja Lütjen; Sabine Soltek; Sigrid Hoffmann; Heinrich Körner; Martina Deckert
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

8.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

9.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10

10.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  21 in total

1.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

2.  Evolution-Driven Attenuation of Alphaviruses Highlights Key Glycoprotein Determinants Regulating Viral Infectivity and Dissemination.

Authors:  Maria G Noval; Bruno A Rodriguez-Rodriguez; Margarita V Rangel; Kenneth A Stapleford
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

3.  Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.

Authors:  Jun P Hong; Mary K McCarthy; Bennett J Davenport; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner.

Authors:  K J Rogers; S Jones-Burrage; W Maury; S Mukhopadhyay
Journal:  Virology       Date:  2020-01-07       Impact factor: 3.616

5.  Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes.

Authors:  Julie M Fox; Vicky Roy; Bronwyn M Gunn; Ling Huang; Melissa A Edeling; Matthias Mack; Daved H Fremont; Benjamin J Doranz; Syd Johnson; Galit Alter; Michael S Diamond
Journal:  Sci Immunol       Date:  2019-02-22

6.  Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.

Authors:  Marissa C Locke; Lindsey E Fox; Bria F Dunlap; Alissa R Young; Kristen Monte; Deborah J Lenschow
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

7.  Microbiome-mediated incapacitation of interferon lambda production in the oral mucosa.

Authors:  Carlos J Rodriguez-Hernandez; Kevin J Sokoloski; Kendall S Stocke; Himabindu Dukka; Shunying Jin; Melissa A Metzler; Konstantin Zaitsev; Boris Shpak; Daonan Shen; Daniel P Miller; Maxim N Artyomov; Richard J Lamont; Juhi Bagaitkar
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

8.  Chikungunya virus replication in skeletal muscle cells is required for disease development.

Authors:  Anthony J Lentscher; Mary K McCarthy; Nicholas A May; Bennett J Davenport; Stephanie A Montgomery; Krishnan Raghunathan; Nicole McAllister; Laurie A Silva; Thomas E Morrison; Terence S Dermody
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

9.  Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.

Authors:  Ivan Delgado-Enciso; Juan Paz-Garcia; Carlos E Barajas-Saucedo; Karen A Mokay-Ramírez; Carmen Meza-Robles; Rodrigo Lopez-Flores; Marina Delgado-Machuca; Efren Murillo-Zamora; Jose A Toscano-Velazquez; Josuel Delgado-Enciso; Valery Melnikov; Mireya Walle-Guillen; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; Eduardo J Danielewicz-Mata; Pablo J Mandujano-Diaz; José Guzman-Esquivel; Daniel A Montes-Galindo; Henry Perez-Martinez; Jesus M Jimenez-Villegaz; Alejandra E Hernandez-Rangel; Patricia Montes-Diaz; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Idalia Garza-Veloz; Daniel Tiburcio-Jimenez; Sergio A Zaizar-Fregoso; Fidadelfo Gonzalez-Alcaraz; Laydi Gutierrez-Gutierrez; Luciano Diaz-Lopez; Mario Ramirez-Flores; Hannah P Guzman-Solorzano; Gustavo Gaytan-Sandoval; Carlos R Martinez-Perez; Francisco Espinoza-Gómez; Fabián Rojas-Larios; Michael J Hirsch-Meillon; Luz M Baltazar-Rodriguez; Enrique Barrios-Navarro; Vladimir Oviedo-Rodriguez; Martha A Mendoza-Hernandez; Emilio Prieto-Diaz-Chavez; Brenda A Paz-Michel
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 10.  Arboviruses and Muscle Disorders: From Disease to Cell Biology.

Authors:  Claudia Filippone; Vincent Legros; Patricia Jeannin; Valérie Choumet; Gillian Butler-Browne; Jim Zoladek; Vincent Mouly; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2020-06-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.